FDA GenAI Medical Device Regulation: Key Considerations Before the October 19, 2026 Comment Deadline

Medical Device Global Market Access · Oct 17, 2026 · 5m

The US FDA is considering a new 'total product lifecycle' approach for regulating medical devices that use Generative AI (GenAI). This episode breaks down the key elements of the FDA's discussion paper, including the unique risks the agency has identified, such as AI 'hallucinations' and automation bias. We discuss why this shift to continuous oversight is being proposed and what it means for manufacturers. Most importantly, we highlight the critical October 19, 2026, deadline for submitting public comment and provide practical steps your team can take now to prepare and help shape future…